Judge Reverses Consolidation Of Bayer FCA Suits
A New Jersey federal judge on Tuesday separated a consolidated false claims whistleblower lawsuit over allegations Bayer AG wrongly promoted off-label uses for its heart surgery drug Trasylol, saying the two...To view the full article, register now.
Already a subscriber? Click here to view full article